Page last updated: 2024-10-23

bisbenzimidazole and Hyperglycemia, Postprandial

bisbenzimidazole has been researched along with Hyperglycemia, Postprandial in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patel, SR1
Kvols, LK1
Rubin, J1
O'Connell, MJ1
Edmonson, JH1
Ames, MM1
Kovach, JS1

Trials

1 trial available for bisbenzimidazole and Hyperglycemia, Postprandial

ArticleYear
Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma.
    Investigational new drugs, 1991, Volume: 9, Issue:1

    Topics: Adult; Bisbenzimidazole; Carcinoma, Intraductal, Noninfiltrating; Drug Administration Schedule; Drug

1991